IOVS SCIENCE Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crosson, C. E.
Right arrow Articles by Gray, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosson, C. E.
Right arrow Articles by Gray, T.

Investigative Ophthalmology & Visual Science, Vol 37, 1833-1839, Copyright © 1996 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Characterization of ocular hypertension induced by adenosine agonists

CE Crosson and T Gray
Department of Ophthalmology, Texas Tech University Health Sciences Center, Lubbock 79430, USA.

PURPOSE. Previous studies have shown that adenosine agonists may induce a rise in intraocular pressure (IOP), a reduction in IOP, or both. Although the reduction in IOP results from the activation of adenosine A1 receptors, the mechanisms responsible for the rise in IOP have not been investigated. This study examines the receptors and mechanisms responsible for the adenosine agonist-induced rise in IOP. METHODS. The ocular effects of the nonselective adenosine agonist NECA, the relatively selective adenosine A2 agonist CV-1808, the A2a agonist CGS- 21680, and the A1 agonist R-PIA were evaluated. RESULTS. The topical administration of CV-1808 produced a rapid rise in IOP, with a maximum increase of 15.6 +/- 1.6 mm Hg. Dose-response curves demonstrated that each agonist produced a dose-related rise in IOP with the following rank order of potency: NECA > CV-1808 > > R-PIA = CGS-21680. At times corresponding to the rise in IOP, the administration of high doses of CV-1808 (165 micrograms) produced a significant increase in aqueous humor flow and protein concentration. Increases in IOP and aqueous humor protein levels induced by CV-1808 were blocked by pretreatment with the adenosine A2 antagonist DMPX. In vitro studies demonstrated that CV-1808 did not alter cyclic adenosine monophosphate production in the rabbit iris-ciliary body. In cats, topical administration of CV- 1808 produced a rapid rise in IOP, with a maximum increase of 8.1 +/- 2.4 mm Hg and an ED50 of 73 +/- 2.9 micrograms. This rise in IOP was blocked by DMPX pretreatment. CONCLUSIONS. These data demonstrate that adenosine receptor agonists can induce an acute rise in IOP in rabbits and cats. On the basis of pharmacologic characteristics, the rise in IOP is consistent with the activation of ocular adenosine A2 receptors. Functional studies indicate that at high doses, this rise in IOP involves an increase in aqueous flow and the breakdown of the blood- aqueous barrier.


This article has been cited by other articles:


Home page
IOVSHome page
U. Schlotzer-Schrehardt, M. Zenkel, U. Decking, D. Haubs, F. E. Kruse, A. Junemann, M. Coca-Prados, and G. O. H. Naumann
Selective Upregulation of the A3 Adenosine Receptor in Eyes with Pseudoexfoliation Syndrome and Glaucoma
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2023 - 2034.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Gomes, S. P. Srinivas, W. Van Driessche, J. Vereecke, and B. Himpens
ATP Release through Connexin Hemichannels in Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1208 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. O. Karl, J. C. Fleischhauer, W. D. Stamer, K. Peterson-Yantorno, C. H. Mitchell, R. A. Stone, and M. M. Civan
Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C784 - C794.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Pintor, T. Pelaez, and A. Peral
Adenosine Tetraphosphate, Ap4, a Physiological Regulator of Intraocular Pressure in Normotensive Rabbit Eyes
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Polska, P. Ehrlich, A. Luksch, G. Fuchsjager-Mayrl, and L. Schmetterer
Effects of Adenosine on Intraocular Pressure, Optic Nerve Head Blood Flow, and Choroidal Blood Flow in Healthy Humans
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3110 - 3114.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Y. Avila, R. A. Stone, and M. M. Civan
Knockout of A3 Adenosine Receptors Reduces Mouse Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3021 - 3026.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. A. Farahbakhsh and M. C. Cilluffo
P2 Purinergic Receptor-Coupled Signaling in the Rabbit Ciliary Body Epithelium
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2317 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. E. Knight, P. Bodin, W. C. De Groat, and G. Burnstock
ATP is released from guinea pig ureter epithelium on distension
Am J Physiol Renal Physiol, February 1, 2002; 282(2): F281 - F288.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. E. Crosson
Intraocular Pressure Responses to the Adenosine Agonist Cyclohexyladenosine: Evidence for a Dual Mechanism of Action
Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1837 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. A. Carre, C. H. Mitchell, K. Peterson-Yantorno, M. Coca-Prados, and M. M. Civan
Similarity of A3-adenosine and swelling-activated Cl- channels in nonpigmented ciliary epithelial cells
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C440 - C451.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. E. Crosson and M. Petrovich
Contributions of Adenosine Receptor Activation to the Ocular Actions of Epinephrine
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. H. Mitchell, K. Peterson-Yantorno, D. A. Carre, A. M. McGlinn, M. Coca-Prados, R. A. Stone, and M. M. Civan
A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells
Am J Physiol Cell Physiol, March 1, 1999; 276(3): C659 - C666.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. H. Mitchell, D. A. Carre, A. M. McGlinn, R. A. Stone, and M. M. Civan
A release mechanism for stored ATP in ocular ciliary epithelial cells
PNAS, June 9, 1998; 95(12): 7174 - 7178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. A. Carre, C. H. Mitchell, K. Peterson-Yantorno, M. Coca-Prados, and M. M. Civan
Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells
Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1354 - C1361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association for Research in Vision and Ophthalmology